RedC Biotech is a pre-clinical, development stage company aiming at saving lives worldwide. RedC is developing a new, process, to create universal red blood cells from stem cells using a patented cultivation technology. It is a highly scalable process for production that can meet the global demand for safe red blood cell transfusions for anyone, anywhere. The universal red blood cells provided by RedC Biotech will be a blood type that is suitable for almost every patient and will have the same potency as the currently used red blood cell transfusion
RedC Biotech collaborates with leading industry, academia and government organizations.
Cumulative Funding Raised Over Time ($)
Employees Over Time
RedC Biotech Climate Tech relevance
null
Latest News
No Data, yet.
Sorry, no content found under this section.
Jun 12, 2022
nocamels.com
Israeli Company Produces Donor-Less Blood In Lab To Alleviate Shortages
#Customers
Apr 25, 2022
www.israel21c.org
The startup aiming to make blood donations a thing of the past
#Customers
Mar 22, 2022
www.calcalist.co.il
ארי גרגיר מחברת Red-C Biotech הוא הזוכה בתחרות קרן זיו אבירם בדובאי כלכליסט